Discussion

Osteosarcoma (OS) involving the gastrointestinal tract or peritoneal cavity is exceptionally rare and encompasses two distinct clinicopathologic settings: metastatic skeletal osteosarcoma involving the bowel or peritoneum, and primary extraskeletal osteosarcoma arising in intra-abdominal soft tissue with secondary intestinal invasion. 

Four recent case-based publications illustrate the major presentations(1-4). Patients with metastatic disease developed gastrointestinal bleeding, severe anemia, intussusception, obstruction, or diffuse ossified peritoneal disease, usually after pulmonary metastases and intensive multimodal treatment. In contrast, primary intra-abdominal extraskeletal osteosarcoma presented as a progressively enlarging calcified mass without an osseous primary.

Macroscopically like small intestinal GIST, this tumor seems to arise from the wall of the digestive tract and extends in both directions; inward toward the mucosa and outward to the serosa (Figure 1). The clinical diagnosis suspicious of a small intestinal GIST.  

Microscopically (Figure 2 to 5), tumor infiltrates the small intestinal wall, protrudes into the lumen with ulcerative surface, and extending into the subserosa. Tumor cells similar to conventional high-grade osteosarcoma within bone that show pleomorphic nuclei and increased mitotic activity with malignant osteoid or immature bone production.

The key microscopic features of osteosarcoma include

• Neoplastic Osteoid: Seen as pink, amorphous, lace-like or coarse trabeculae of new bone laid down directly by tumor cells, often with variable mineralization (dark purple/blue calcification). 

• Cellular Pleomorphism: Tumor cells vary widely in size and shape, appearing spindle-shaped, polygonal, or epithelioid with abundant abnormal forms. 

• Nuclei are large, hyperchromatic (darkly stained), pleomorphic, and vesicular with prominent nucleoli. 

• Brisk Mitotic Activity: Frequent and atypical mitotic figures reflect rapid, aggressive cell division.

• Infiltration: The malignant cells permeate and destroy the surrounding tissue. 

Establishing a definitive diagnosis in poorly differentiated or limited biopsy specimens often poses a significant diagnostic dilemma, requiring the integration of morphologic concordance with the known skeletal primary and the systematic exclusion of common intestinal sarcomas. Our diagnostic strategy employed a hypothesis-driven IHC approach; gastrointestinal stromal tumor (GIST) was ruled out via negative CD117 and DOG-1 staining, while diffuse nuclear expression of SATB2 definitively confirmed osteoblastic differentiation in the pleomorphic tumor cells (Figure 6). 

Notably, no antibody is pathognomonic for osteosarcoma without malignant osteoid or definitive Clinico-radiologic correlation. Consequently, immunohistochemical staining must be interpreted strictly within the atypical lesional cells rather than in background reactive osteoblasts, entrapped epithelium, or metaplastic bone(5, 6).

Osteosarcoma versus GIST with osseous differentiation

Osseous differentiation or metaplasia is exceptionally rare in gastrointestinal stromal tumor (GIST), but it is an important mimic of intestinal or extraskeletal osteosarcoma. Reported gastric GISTs have contained stromal calcification and mature bone while retaining typical spindle or epithelioid morphology and strong KIT and DOG1 expression(7, 8).

The critical distinction is whether atypical tumor cells directly produce malignant osteoid. In osteosarcoma, osteoid is an intrinsic malignant tumor product and is closely associated with cytologically malignant cells. In reported osseous GISTs, the bone has been described as benign osseous metaplasia or mature bone formation within the tumor stroma, without a malignant osteoid-producing cell population(7-9).  

References

1. Berhe S, Danzer E, Meyers P, Behr G, LaQuaglia MP, Price AP. Unusual abdominal metastases in osteosarcoma. J Pediatr Surg Case Rep. 2018;28:13-6.

2. Wang T, Liao S, Ding X, Anil KC, Huang Q, Lin C, et al. Intraperitoneal extraosseous osteosarcoma: a case report and literatures review. BMC Musculoskeletal Disorders. 2020;21(1):452.

3. Harne PS, Salooja I, Thomas P, Rivera AS, Cardenas C, Zamir A. Gone to Guts: Osteosarcoma With Metastasis to Small and Large Intestines Presenting as Recurrent Bleeding. ACG Case Rep J. 2024;11(1):e01224.

4. Otsu W, Shitomi Y, Ninomiya S, Miyoshino W, Ichimanda M, Aoyama Y, et al. Small Bowel Metastasis of Osteosarcoma Presenting with Intussusception: A Case Report. Surg Case Rep. 2026;12(1).

5. Milton S, Prabhu AJ, Titus VTK, John R, Backianathan S, Madhuri V. Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors. J Pathol Transl Med. 2022;56(5):270-80.

6. El Motassime A, Vitiello R, Comodo RM, Capece G, Bocchino G, Bocchi MB, et al. Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications. Biology (Basel). 2025;14(10).

7. Giorlandino A, Caltabiano R, Gurrera A, Lanzafame S. Gastrointestinal stromal tumour of the stomach with osseous differentiation: a case report. Pathologica. 2014;106(4):345-7.

8. Al-Maghrabi H, Meliti A. Gastric gastrointestinal stromal tumor with osseous differentiation and stromal calcification: A case report and review of literature. SAGE Open Med Case Rep. 2017;5:2050313x17746310.

9. Al Saleem MA, Khan NM, ElSharkawy TM. Multifocal gastrointestinal stromal tumor with osseous metaplasia: a case report. Journal of Medical Case Reports. 2023;17(1):546.